[ET Net News Agency, 3 November 2023] EVEREST MED-B (01952) fell 10.3% to HK$28.
It hits an intra-day low of HK$27.95, and an intra-day high of HK$32.1. The total shares
traded was 8.56 million, with a value of HK$252.49m. The active buy/sell ratio is 36:64,
with net selling turnover of HK$67.46m. CHINA INNOVATION MARKET SER accounts for greatest
net responsive buying turnover of HK$18.04m, with volume weighted average price of
HK$29.442. CITIGROUP GLOBAL accounts for greatest net responsive selling turnover of
HK$9.74m, with volume weighted average price of HK$30.453.
Basic Information
=================
----------------------------------
Nominal 28.000 % Chg -10.26%
High 32.100 Low 27.950
Shares Tr 8.56m Turnover 252.49m
10-D SMA 26.325 %H.V 85.286
20-D SMA 26.012 VWAP 29.508
50-D SMA 22.149 RSI14 58.523
----------------------------------
Status: Active buy/sell ratio is 36:64, with net selling turnover of HK$67.46m
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
EVEREST MED-B (01952) 28.00 -10.26
GENSCRIPT BIO (01548) 22.20 -2.42
INNOVENT BIO (01801) 45.50 -2.36
WUXI BIO (02269) 47.90 +1.91
WUXI APPTEC (02359) 95.10 +3.03
BEIGENE (06160) 110.40 +0.55
CANSINOBIO (06185) 25.45 -1.16
ZAI LAB (09688) 19.98 +0.60
AKESO (09926) 44.10 -2.86
ALPHAMAB-B (09966) 11.56 -0.86
---------------------------------------------
(ed)